Cargando…
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites
[Image: see text] Human African trypanosomiasis (HAT), Chagas disease, and leishmaniasis present a significant burden across the developing world. Existing therapeutics for these protozoal neglected tropical diseases suffer from severe side effects and toxicity. Previously, NEU-1045 (3) was identifi...
Autores principales: | Devine, William, Thomas, Sarah M., Erath, Jessey, Bachovchin, Kelly A., Lee, Patricia J., Leed, Susan E., Rodriguez, Ana, Sciotti, Richard J., Mensa-Wilmot, Kojo, Pollastri, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346991/ https://www.ncbi.nlm.nih.gov/pubmed/28337329 http://dx.doi.org/10.1021/acsmedchemlett.7b00011 |
Ejemplares similares
-
Protozoan Parasite
Growth Inhibitors Discovered by
Cross-Screening Yield Potent Scaffolds for Lead Discovery
por: Devine, William, et al.
Publicado: (2015) -
Anilinoquinoline based inhibitors of trypanosomatid proliferation
por: Ferrins, Lori, et al.
Publicado: (2018) -
Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2016) -
Erratum: Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2017) -
Identification of “Preferred” Human
Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases
Better than Others for Inhibitor Repurposing?
por: Amata, Emanuele, et al.
Publicado: (2016)